Literature DB >> 25788612

HIV Subspecialty Care in Correctional Facilities Using Telemedicine.

Jeremy D Young1, Mahesh Patel2.   

Abstract

In the United States, prisons and jails contain a population at high risk for HIV infection with a relatively large proportion known to be HIV positive. However, many incarcerated persons lack access to subspecialty HIV care due to barriers of geography and travel. Telemedicine clinics can remove these barriers, increasing access to expert, multidisciplinary care. With telemedicine, correctional facilities can provide up-to-date, evidence-based HIV management, which may lead to improved compliance, greater virologic suppression, improved CD4 T-cell counts, fewer adverse drug interactions, and decreased transmission in the community. While HIV care in prisons is an example of harnessing this technology, telemedicine can be used for the diagnosis and management of multiple acute and chronic diseases for underserved populations.
© The Author(s) 2015.

Entities:  

Keywords:  HIV; correctional health care; prisons; telehealth; telemedicine

Mesh:

Year:  2015        PMID: 25788612     DOI: 10.1177/1078345815572863

Source DB:  PubMed          Journal:  J Correct Health Care        ISSN: 1078-3458


  3 in total

1.  Attitudes and acceptability of children, caregivers, and healthcare providers about using telemedicine for pediatric HIV care in a resource-limited setting.

Authors:  Mamta Manglani; Mamatha Murad Lala; Yashwant Gabhale; Sudha Balakrishnan; Khanindra Bhuyan; B B Rewari; Maninder Singh Setia
Journal:  PLoS One       Date:  2022-05-25       Impact factor: 3.752

Review 2.  Recent Evidence for Emerging Digital Technologies to Support Global HIV Engagement in Care.

Authors:  Kate Jongbloed; Sunjit Parmar; Mia van der Kop; Patricia M Spittal; Richard T Lester
Journal:  Curr HIV/AIDS Rep       Date:  2015-12       Impact factor: 5.071

Review 3.  Electronic consultation in correctional facilities worldwide: a scoping review.

Authors:  Claire Sethuram; Mary Helmer-Smith; Sathya Karunananthan; Erin Keely; Jatinderpreet Singh; Clare Liddy
Journal:  BMJ Open       Date:  2022-08-03       Impact factor: 3.006

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.